Weiss Multi-Strategy Advisers’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-245
Closed -$278K 444
2019
Q4
$278K Sell
245
-25
-9% -$27.2K ﹤0.01% 563
2019
Q3
$321K Buy
+270
New +$412K 0.01% 519
2019
Q1
Sell
-193
Closed -$340K 517
2018
Q4
$248K Sell
193
-309
-62% -$474K 0.01% 400
2018
Q3
$949K Buy
+502
New +$1.04M 0.03% 401
2018
Q1
Sell
-154
Closed -$356K 538
2017
Q4
$356K Buy
+154
New +$313K 0.01% 515
2015
Q2
Sell
-154
Closed -$242K 447
2015
Q1
$242K Sell
154
-2,162
-93% -$2.85M 0.01% 401
2014
Q4
$2.75M Sell
2,316
-10,802
-82% -$7.22M 0.09% 187
2014
Q3
$6.1M Buy
13,118
+7,714
+143% +$3.56M 0.15% 162
2014
Q2
$2.7M Buy
+5,404
New +$1.73M 0.06% 295
2014
Q1
Sell
-12,738
Closed -$3.46M 964
2013
Q4
$3.46M Hold
12,738
0.07% 274
2013
Q3
$4.45M Buy
+12,738
New +$4.73M 0.1% 240

Other funds holding BLUE

Weiss Multi-Strategy Advisers's BLUE Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 245 shares — an estimated $278K sold.

Weiss Multi-Strategy Advisers first reported a position in BLUE in Q3 2013 and held it in 11 quarters. The position peaked at $6.1M in Q3 2014. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • Weiss Multi-Strategy Advisers reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 245 bluebird bio shares in Q1 2020, an estimated $278K.
  • Weiss Multi-Strategy Advisers first reported a position in bluebird bio in Q3 2013 and held it in 11 quarters.
  • Weiss Multi-Strategy Advisers's bluebird bio position peaked at $6.1M in Q3 2014.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.